Advisory Alpha, LLC Intellia Therapeutics, Inc. Transaction History

Advisory Alpha, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$18.83 - $63.53 $1,882 - $6,353	-100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.47 - $24.93 $1,747 - $2,493	100 New	100 $2,000
Q2 2020 Aug 14, 2020	SELL	$11.14 - $22.87 $1,114 - $2,287	-100 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$13.07 - $18.51 $1,307 - $1,851	100 New	100 $1,000
Q2 2019 Aug 16, 2019	SELL	$13.88 - $18.41 $1,388 - $1,841	-100 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$12.79 - $17.62 $1,279 - $1,762	100 New	100 $0

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.07B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.